Response to the ASHM 2023 statement on the use of doxy‐PEP in Australia: considerations and recommendations

Saved in:
Bibliographic Details
Published in:Medical journal of Australia 2024-04, Vol.220 (7), p.356-360
Main Authors: Bell, Sara F E, Sweeney, Emma L, Kong, Fabian Y S, Whiley, David M, Bradshaw, Catriona S, Tickner, Jacob A
Format: Article
Language:English
Subjects:
Drug resistance, microbial
Sexually transmitted diseases
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c3245-65211d5f2962b3572006fd16783d798cfb632b0d3170261faad6ce75095fbbc93
container_end_page 360
container_issue 7
container_start_page 356
container_title Medical journal of Australia
container_volume 220
creator Bell, Sara F E
Sweeney, Emma L
Kong, Fabian Y S
Whiley, David M
Bradshaw, Catriona S
Tickner, Jacob A
description
doi_str_mv 10.5694/mja2.52255
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2957164349</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2957164349</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3245-65211d5f2962b3572006fd16783d798cfb632b0d3170261faad6ce75095fbbc93</originalsourceid><addsrcrecordid>eNp9kEtOwzAQQC0EoqWw4QDIS4SUYo9ju2EXVYWCWlHxkdhFTuyIVElc4kTQHUfgjJyEtCksWY1n_PQWD6FTSoZcBP5lsVQw5ACc76E-ZSA8zqTcR31CgHsSgpceOnJu2a6UgzxEPTbyZeAD76PiwbiVLZ3BtcX1q8Hh43SOgQDDrla1KUxZY1tuv5qWsinW9mP9_fm1mCxwVuKwcXWl8kxd4aT1ZNpUqs7aF1alxpVJbNE6dHc7Rgepyp052c0Ber6ePI2n3uz-5nYczryEgc89wYFSzVMIBMSMSyBEpJoKOWJaBqMkjQWDmGhGJQFBU6W0SIzkJOBpHCcBG6Dzzruq7FtjXB0VmUtMnqvS2MZFEHBJhc_8DXrRoUllnatMGq2qrFDVOqIk2uSNNnmjbd4WPtt5m7gw-g_97dkCtAPes9ys_1FF87sQOukP-26EnQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2957164349</pqid></control><display><type>article</type><title>Response to the ASHM 2023 statement on the use of doxy‐PEP in Australia: considerations and recommendations</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Bell, Sara F E ; Sweeney, Emma L ; Kong, Fabian Y S ; Whiley, David M ; Bradshaw, Catriona S ; Tickner, Jacob A</creator><creatorcontrib>Bell, Sara F E ; Sweeney, Emma L ; Kong, Fabian Y S ; Whiley, David M ; Bradshaw, Catriona S ; Tickner, Jacob A</creatorcontrib><identifier>ISSN: 0025-729X</identifier><identifier>EISSN: 1326-5377</identifier><identifier>DOI: 10.5694/mja2.52255</identifier><identifier>PMID: 38479425</identifier><language>eng</language><publisher>Australia</publisher><subject>Drug resistance, microbial ; Sexually transmitted diseases</subject><ispartof>Medical journal of Australia, 2024-04, Vol.220 (7), p.356-360</ispartof><rights>2024 The Authors. published by John Wiley &amp; Sons Australia, Ltd on behalf of AMPCo Pty Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3245-65211d5f2962b3572006fd16783d798cfb632b0d3170261faad6ce75095fbbc93</cites><orcidid>0000-0002-3199-6432 ; 0000-0002-9349-3080</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38479425$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bell, Sara F E</creatorcontrib><creatorcontrib>Sweeney, Emma L</creatorcontrib><creatorcontrib>Kong, Fabian Y S</creatorcontrib><creatorcontrib>Whiley, David M</creatorcontrib><creatorcontrib>Bradshaw, Catriona S</creatorcontrib><creatorcontrib>Tickner, Jacob A</creatorcontrib><title>Response to the ASHM 2023 statement on the use of doxy‐PEP in Australia: considerations and recommendations</title><title>Medical journal of Australia</title><addtitle>Med J Aust</addtitle><subject>Drug resistance, microbial</subject><subject>Sexually transmitted diseases</subject><issn>0025-729X</issn><issn>1326-5377</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><recordid>eNp9kEtOwzAQQC0EoqWw4QDIS4SUYo9ju2EXVYWCWlHxkdhFTuyIVElc4kTQHUfgjJyEtCksWY1n_PQWD6FTSoZcBP5lsVQw5ACc76E-ZSA8zqTcR31CgHsSgpceOnJu2a6UgzxEPTbyZeAD76PiwbiVLZ3BtcX1q8Hh43SOgQDDrla1KUxZY1tuv5qWsinW9mP9_fm1mCxwVuKwcXWl8kxd4aT1ZNpUqs7aF1alxpVJbNE6dHc7Rgepyp052c0Ber6ePI2n3uz-5nYczryEgc89wYFSzVMIBMSMSyBEpJoKOWJaBqMkjQWDmGhGJQFBU6W0SIzkJOBpHCcBG6Dzzruq7FtjXB0VmUtMnqvS2MZFEHBJhc_8DXrRoUllnatMGq2qrFDVOqIk2uSNNnmjbd4WPtt5m7gw-g_97dkCtAPes9ys_1FF87sQOukP-26EnQ</recordid><startdate>20240415</startdate><enddate>20240415</enddate><creator>Bell, Sara F E</creator><creator>Sweeney, Emma L</creator><creator>Kong, Fabian Y S</creator><creator>Whiley, David M</creator><creator>Bradshaw, Catriona S</creator><creator>Tickner, Jacob A</creator><scope>24P</scope><scope>WIN</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3199-6432</orcidid><orcidid>https://orcid.org/0000-0002-9349-3080</orcidid></search><sort><creationdate>20240415</creationdate><title>Response to the ASHM 2023 statement on the use of doxy‐PEP in Australia: considerations and recommendations</title><author>Bell, Sara F E ; Sweeney, Emma L ; Kong, Fabian Y S ; Whiley, David M ; Bradshaw, Catriona S ; Tickner, Jacob A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3245-65211d5f2962b3572006fd16783d798cfb632b0d3170261faad6ce75095fbbc93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Drug resistance, microbial</topic><topic>Sexually transmitted diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bell, Sara F E</creatorcontrib><creatorcontrib>Sweeney, Emma L</creatorcontrib><creatorcontrib>Kong, Fabian Y S</creatorcontrib><creatorcontrib>Whiley, David M</creatorcontrib><creatorcontrib>Bradshaw, Catriona S</creatorcontrib><creatorcontrib>Tickner, Jacob A</creatorcontrib><collection>Open Access: Wiley-Blackwell Open Access Journals</collection><collection>Wiley-Blackwell Open Access Backfiles (Open Access)</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Medical journal of Australia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bell, Sara F E</au><au>Sweeney, Emma L</au><au>Kong, Fabian Y S</au><au>Whiley, David M</au><au>Bradshaw, Catriona S</au><au>Tickner, Jacob A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Response to the ASHM 2023 statement on the use of doxy‐PEP in Australia: considerations and recommendations</atitle><jtitle>Medical journal of Australia</jtitle><addtitle>Med J Aust</addtitle><date>2024-04-15</date><risdate>2024</risdate><volume>220</volume><issue>7</issue><spage>356</spage><epage>360</epage><pages>356-360</pages><issn>0025-729X</issn><eissn>1326-5377</eissn><cop>Australia</cop><pmid>38479425</pmid><doi>10.5694/mja2.52255</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0002-3199-6432</orcidid><orcidid>https://orcid.org/0000-0002-9349-3080</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0025-729X
ispartof Medical journal of Australia, 2024-04, Vol.220 (7), p.356-360
issn 0025-729X
1326-5377
language eng
recordid cdi_proquest_miscellaneous_2957164349
source Wiley-Blackwell Read & Publish Collection
subjects Drug resistance, microbial
Sexually transmitted diseases
title Response to the ASHM 2023 statement on the use of doxy‐PEP in Australia: considerations and recommendations
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T12%3A44%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Response%20to%20the%20ASHM%202023%20statement%20on%20the%20use%20of%20doxy%E2%80%90PEP%20in%20Australia:%20considerations%20and%20recommendations&rft.jtitle=Medical%20journal%20of%20Australia&rft.au=Bell,%20Sara%20F%E2%80%89E&rft.date=2024-04-15&rft.volume=220&rft.issue=7&rft.spage=356&rft.epage=360&rft.pages=356-360&rft.issn=0025-729X&rft.eissn=1326-5377&rft_id=info:doi/10.5694/mja2.52255&rft_dat=%3Cproquest_cross%3E2957164349%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3245-65211d5f2962b3572006fd16783d798cfb632b0d3170261faad6ce75095fbbc93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2957164349&rft_id=info:pmid/38479425&rfr_iscdi=true